Today: 7 February 2026
Subscribe
Browse Category

Financial Analysis News 2 January 2026

Neptune Insurance (NP) stock drops 4% in 2026’s first session as risk appetite cools

Neptune Insurance (NP) stock drops 4% in 2026’s first session as risk appetite cools

NEW YORK, Jan 2, 2026, 15:01 ET — Regular session Neptune Insurance Holdings Inc (NYSE: NP) shares fell about 4% to $27.99 in afternoon trading on Friday, underperforming the broader market in the first U.S. session of 2026. The move matters because Neptune is a recently listed name that has drawn momentum interest, and early-year rebalancing can amplify swings in smaller, newer stocks. It also lands as investors refocus on the macro outlook for rates and growth, a key driver for insurance-related valuations because insurers invest premiums largely in bonds and rate expectations can change sector sentiment quickly. U.S. stocks
2 January 2026
·····
T-Mobile stock slips in 2026’s first session as investors eye Feb. 11 targets update

T-Mobile stock slips in 2026’s first session as investors eye Feb. 11 targets update

NEW YORK, Jan 2, 2026, 14:45 ET — Regular session T-Mobile US, Inc. (TMUS) shares fell 1.1% to $200.81 in afternoon trading, after swinging between $199.75 and $203.04. The decline comes as investors reset positions for 2026 and refocus on the carrier’s next major disclosure cycle, when management is expected to refresh its medium-term outlook. On the consumer front, T-Mobile’s support page shows an Apple TV+ price change taking effect January 1: customers billed through the carrier will see $12.99 per month, while eligible plans apply a $9.99 discount, leaving a $3 monthly charge “after your T-Mobile discount,” with subscription
2 January 2026
····
Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next

Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next

NEW YORK, January 2, 2026, 2:30 PM ET — Regular session Corcept Therapeutics Incorporated shares were up 5.7% at $36.77 on Friday afternoon, after a sharp selloff earlier in the week tied to a U.S. regulatory setback for its experimental drug relacorilant. The bounce matters because the FDA’s decision hit what investors had seen as a key growth driver beyond Corcept’s marketed therapy, and it reset expectations for how quickly relacorilant can reach patients in the company’s lead endocrine indication. A complete response letter is the FDA’s notice that a drug application cannot be approved as filed. For investors, it
2 January 2026
·····
Disney stock slides today as DIS tracks sector weakness despite ‘Zootopia 2’ box-office record

Disney stock slides today as DIS tracks sector weakness despite ‘Zootopia 2’ box-office record

NEW YORK, Jan 2, 2026, 13:19 ET — Regular session Walt Disney Co shares fell 1.5% to $112.11 in early afternoon trading on Friday, sliding with broader consumer-discretionary weakness. The stock traded between $111.65 and $113.98 in the session, while the Consumer Discretionary Select Sector SPDR ETF was down about 1.1%. The move comes in the first trading session of 2026, as investors reassess last year’s rally and look for fresh catalysts heading into January’s run of economic data and corporate updates. Disney sits at the intersection of consumer spending, streaming subscriptions and moviegoing, leaving the shares sensitive to shifts
2 January 2026
····
Adobe stock slides nearly 5% today as software names stumble into 2026

Adobe stock slides nearly 5% today as software names stumble into 2026

NEW YORK, January 2, 2026, 1:28 PM ET — Regular session Adobe Inc shares fell nearly 5% on Friday, giving back an early pop as U.S. markets opened 2026 in a choppy, rate-sensitive tape. Adobe (ADBE.O) was down $17.07, or 4.9%, at $332.92 at 1:28 p.m. ET, after opening at $349.86 and trading as low as $332.24. The slide matters now because investors are resetting positions for a packed January calendar that can reshape interest-rate expectations, a key driver for growth stocks like software. Next week brings an early test: the U.S. jobs report due Jan. 9 and the consumer
2 January 2026
····
Lam Research stock jumps nearly 5% today as chip-equipment rally kicks off 2026

Lam Research stock jumps nearly 5% today as chip-equipment rally kicks off 2026

NEW YORK, Jan 2, 2026, 12:25 ET — Regular session Lam Research (LRCX) shares rose $8.31, or 4.9%, to $179.49 on Friday, outperforming the broader market in the first regular session of 2026. The move matters now because chip-equipment stocks often trade as a direct read-through on how aggressively chipmakers plan to spend on new capacity. Those spending plans can swing quickly with demand for artificial intelligence hardware and memory chips. Reuters Friday’s gains also reflect a risk-on tone at the start of the year after a choppy finish to 2025, with technology shares helping lift U.S. equities, Reuters reported.
2 January 2026
·····
Sandisk stock jumps 12% to start 2026 — what’s driving SNDK today

Sandisk stock jumps 12% to start 2026 — what’s driving SNDK today

NEW YORK, Jan 2, 2026, 11:44 ET — Regular session Shares of Sandisk Corp (SNDK) jumped nearly 12% on Friday, trading at $265.80 after touching an intraday high of $267.65. The stock swung between $242.00 and $267.65 as about 5.4 million shares changed hands in late morning trade. The move puts Sandisk back on the front foot at the start of 2026, after tech stocks stumbled in the final sessions of 2025. Traders have treated the flash-storage maker as a direct play on AI-linked data-center spending, a theme that has driven sharp rotations across semiconductors and hardware. U.S. stocks opened
2 January 2026
·····
BitMine Immersion (BMNR) stock jumps as Tom Lee presses vote to lift authorized shares to 50 billion

BitMine Immersion (BMNR) stock jumps as Tom Lee presses vote to lift authorized shares to 50 billion

NEW YORK, January 2, 2026, 11:59 ET — Regular session BitMine Immersion Technologies Inc shares climbed on Friday after the company filed new materials aimed at winning shareholder support for a sharp increase in its authorized share count. SEC The move matters because the proposal is headed for a vote this month and could reshape how the company funds itself. Authorized shares set the maximum number of shares a company is allowed to issue under its charter; raising that ceiling can give management flexibility, but it can also heighten dilution concerns for existing holders. It also lands as crypto-sensitive stocks
2 January 2026
·····
D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

NEW YORK, Jan 2, 2026, 12:04 ET — Regular session Shares of D-Wave Quantum Inc. rose about 3% to $26.95 by 12:04 p.m. ET on Friday, the first U.S. trading day of 2026. The NYSE-listed stock traded between $25.44 and $27.64, with about 25.4 million shares changing hands. The move puts attention back on a corner of the market that tends to magnify shifts in risk appetite. With many investors restarting positions after a holiday-thinned finish to 2025, small-cap tech names have been among the first to see fresh flows. D-Wave has two near-term dates traders are circling. It is
2 January 2026
········
Ondas (ONDS) stock jumps after rebrand plan, Florida HQ move and note-extension filing

Ondas (ONDS) stock jumps after rebrand plan, Florida HQ move and note-extension filing

NEW YORK, January 2, 2026, 11:19 ET — Regular session Ondas Holdings Inc shares rose 8.6% to $10.60 as of 11:04 a.m. ET on Friday after the company disclosed plans to change its corporate name to Ondas Inc. and relocate its headquarters to West Palm Beach, Florida. Nearly 49.4 million shares had changed hands, with the stock trading between $9.92 and $10.63. The move matters because small-cap defense and security suppliers often rely on frequent capital raises and new customer wins to fund growth. Investors tend to treat rebrands and headquarters moves as signals about how a company wants to
2 January 2026
·····
JPMorgan stock today: JPM steadies as jobs report and Jan. 13 earnings come into focus

JPMorgan stock today: JPM steadies as jobs report and Jan. 13 earnings come into focus

NEW YORK, Jan 2, 2026, 10:51 ET — Regular session Shares of JPMorgan Chase & Co (JPM.N) were little changed on Friday, as investors turned to fresh economic signals and the start of bank earnings season. The stock was up 0.1% at $322.40 as of 10:33 a.m. ET, after trading between $320.83 and $323.99. The quiet start for JPM stock underscores how quickly attention is shifting from year-end positioning to January’s data docket, which can reset expectations for interest rates and loan demand. The next major rate signal is the U.S. employment report due Jan. 9, which is expected to
2 January 2026
····
AppLovin stock slides into 2026 as investors test its sky-high margins

AppLovin stock slides into 2026 as investors test its sky-high margins

NEW YORK, January 2, 2026, 10:38 ET AppLovin shares fell about 6% on Friday morning, extending a retreat that began in the final days of 2025 as investors reassessed one of the market’s standout momentum names. The move matters at the start of the year because AppLovin’s run-up has made the stock unusually sensitive to valuation questions and any hint that growth is cooling, even without new company-specific news. Wall Street’s focus is narrowing to the next earnings release, with analysts looking for another step-up in profit while revenue growth moderates from last year’s pace. In the latest closing session
2 January 2026
····
1 … 130 131 132 133 134 … 287

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop